CliffBio
small molecule

FLUDARA

FLUDARABINE PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyGenzyme →See this company's full patent-cliff portfolio

Drug detail

Brand nameFLUDARA
Active ingredientFLUDARABINE PHOSPHATE
Strength50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalApril 1991
Marketing statusDISCN

More from Genzyme

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.